Audited Supplier
In This Store
Granules India Limited, incorporated in 1991, is a vertically integrated and fast growing Indian pharmaceutical company headquartered in Hyderabad. With best-in-class facilities and a strong commitment to operational excellence, quality, and customer service, Granules is one of the few pharmaceutical companies globally involved across the entire manufacturing value chain—from Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs) to Finished Dosages (FDs).
Granules serves over 300 customers across regulated and semi-regulated markets, with a global footprint spanning more than 80 countries. The company operates 10 manufacturing facilities—eight in India, two in the USA—and recently expanded its global footprint with the addition of a Contract Development and Manufacturing Organization (CDMO) facility in Europe.
Granules facilities are approved by leading regulatory agencies including the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, KFDA, DEA, MCC, and HALAL.
Year of Establishment: 1984
Total Assets(USD): More than 99,999,999
Total Number of Staff: more than 1000
Main Competitive Advantages: International Approvals/Standards,Production Capacity,Reputation,Quality Service
Other Competitive Advantages: Vertically integrated pharmaceutical manufacturer; strong regulatory track record; global presence; sustainability; portfolio expansion in CNS/ADHD, Oncology, peptides and CDMO;
Patents and Copyrights: During our journey to build Granules’ intellectual property assets, we have filed a total of 119 patent applications and currently hold 10 granted patents. In the last financial year alone, we filed 25 new patent applications across various jurisdictions, including 12 in India, 3 international (PCT) applications, 3 in the USA, and 7 in other countries.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us：
Pharma Sources Insight January 2025
